Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$387.8M
-15.0% from 2023
Prescriptions
602K
$644.35 per claim
Patients
154K
103,230 prescribers
Total spending, 2024
$387.9M
$2,514.55 per patient
Medicare prescription drug plans paid $387.8M for Combivent Respimat in 2024, for 601,845 prescriptions and refills to 154,219 patients (down 15.0% from 2023). The average cost per claim was $644.35.
California had the highest Medicare cost for Combivent Respimat in 2024: $37.3M for 57,874 claims, followed by New York ($26.9M).
Thomas K Chan, pulmonary disease in New York, NY, had the highest Medicare cost for Combivent Respimat in 2024: 1,598 claims costing $793K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Thomas K Chan New York, NY | Pulmonary Disease | 1,598 | 260 | $793K |
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 570 | 123 | $274K |
| Jiansheng Zhao |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 117,711 | 752,670 | 192,356 | $484.5M |
| 2023 | 112,369 | 683,397 | 176,239 | $456.2M |
| 2024 | 103,230 | 601,845 | 154,219 | $387.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 263 |
| 79 |
| $163K |
| Xiangsheng Zheng Birmingham, AL | Internal Medicine | 299 | 47 | $142K |
| Yanhan D Huang Brooklyn, NY | Internal Medicine | 260 | 64 | $135K |
| Frederic D Seifer Potsdam, NY | Pulmonary Disease | 222 | 73 | $130K |
| Yin Fei Hung Bristol, CT | Hospitalist | 217 | 79 | $129K |
| Chih M Chen Springfield, MA | Hospitalist | 202 | 45 | $120K |
| Huan A Le San Diego, CA | Pulmonary Disease | 244 | 38 | $117K |
| Waleed S Najeeb Glendale, WI | Internal Medicine | 206 | 40 | $115K |
| Alan R Nili Irvine, CA | Family Practice | 93 | 21 | $115K |
| Sidharth Bagga Oroville, CA | Internal Medicine | 200 | 52 | $111K |
| John A Fritz Jersey City, NJ | Family Practice | 191 | 33 | $106K |
| Paul A Ikemire New Orleans, LA | Family Practice | 212 | 46 | $105K |
| Dima Adl Milwaukee, WI | Pulmonary Disease | 112 | 32 | $105K |
| Kenneth K Sha Flushing, NY | Pulmonary Disease | 204 | 37 | $102K |
| Ernesto Mejia Morristown, TN | Pulmonary Disease | 154 | 29 | $101K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 103 | 49 | $100K |
| Hagop Bezikian Los Angeles, CA | Internal Medicine | 212 | 31 | $98K |
| Crawford Chung San Francisco, CA | Internal Medicine | 121 | 30 | $96K |
| Valneo M Buttari Mt Vernon, NY | Internal Medicine | 177 | 16 | $96K |
| Reuven Moshenyat Brooklyn, NY | Pulmonary Disease | 192 | 29 | $96K |
| Jeffrey S Lessar Winchester, VA | Pulmonary Disease | 107 | 25 | $92K |
| Jay S Fleitman Northampton, MA | Pulmonary Disease | 91 | 20 | $91K |
| Ajay D Deshpande Terre Haute, IN | Pulmonary Disease | 125 | 34 | $88K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Boehringer Ing. | 602,035 | $387.9M |